Literature DB >> 26263281

Effects of Cardiovascular Disease on Compliance with Cervical and Breast Cancer Screening Recommendations Among Adult Women.

Fangjian Guo1, Jacqueline M Hirth1, Abbey B Berenson1.   

Abstract

BACKGROUND: Cardiovascular disease (CVD) is common among women and is a leading cause of death in the United States. This study assessed the impact of CVD on compliance with the US Preventive Services Task Force guidelines for cervical and breast cancer screening among U.S. adult women.
METHODS: A cross-sectional study was conducted on 17,408 women using data from the National Health Interview Survey 2013. A total of 11,788 respondents (21-65 years old) with complete information on Pap smear and 11,409 women (40+ years old) with complete information on mammography compliance were included. Multivariate logistic regression models were used to assess the impact of CVD on cervical and breast cancer screening practices.
RESULTS: Women with CVD were marginally more likely to have had a mammogram in accordance with guidelines (odds ratio 1.17; 95% confidence interval 1.04-1.31) than those without CVD. However, compliance with Pap tests was similar (80.6% vs 82.3%, p>0.05) between the two groups. Myocardial infarction was associated with reduced odds of Pap smear compliance (odds ratio: 0.30; 95% confidence interval 0.18-0.51).
CONCLUSIONS: Women with prior myocardial infarction should be encouraged to continue receiving regular Pap smears. More research is needed to assess whether observed differences in Pap testing between patients with and without a history of myocardial infarction result from lack of provider recommendation or from patient noncompliance with their recommendations.

Entities:  

Mesh:

Year:  2015        PMID: 26263281      PMCID: PMC4545373          DOI: 10.1089/jwh.2014.5129

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  23 in total

1.  Validity of women's self-reports of cancer screening test utilization in a managed care population.

Authors:  Lee S Caplan; David V McQueen; Judith R Qualters; Marilyn Leff; Carol Garrett; Ned Calonge
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-11       Impact factor: 4.254

2.  Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.

Authors:  Maria Hewitt; Susan S Devesa; Nancy Breen
Journal:  Prev Med       Date:  2004-08       Impact factor: 4.018

Review 3.  Some methodologic lessons learned from cancer screening research.

Authors:  Sally W Vernon; Peter A Briss; Jasmin A Tiro; Richard B Warnecke
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

4.  Competing demands in the office visit: what influences mammography recommendations?

Authors:  P A Nutting; M Baier; J J Werner; G Cutter; C Conry; L Stewart
Journal:  J Am Board Fam Pract       Date:  2001 Sep-Oct

5.  Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association.

Authors:  Harmon Eyre; Richard Kahn; Rose Marie Robertson; Nathaniel G Clark; Colleen Doyle; Yuling Hong; Ted Gansler; Thomas Glynn; Robert A Smith; Kathryn Taubert; Michael J Thun
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

Review 6.  Interactive behavior change technology. A partial solution to the competing demands of primary care.

Authors:  Russell E Glasgow; Sheana S Bull; John D Piette; John F Steiner
Journal:  Am J Prev Med       Date:  2004-08       Impact factor: 5.043

7.  Concordance of self-reported data and medical record audit for six cancer screening procedures.

Authors:  N P Gordon; R A Hiatt; D I Lampert
Journal:  J Natl Cancer Inst       Date:  1993-04-07       Impact factor: 13.506

8.  Predictors of cancer prevention attitudes and participation in cancer screening examinations.

Authors:  R M Bostick; J M Sprafka; B A Virnig; J D Potter
Journal:  Prev Med       Date:  1994-11       Impact factor: 4.018

9.  Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit.

Authors:  D E Montaño; W R Phillips
Journal:  Am J Public Health       Date:  1995-06       Impact factor: 9.308

10.  Validity of Pap smear and mammogram self-reports in a low-income Hispanic population.

Authors:  L Suarez; D A Goldman; N S Weiss
Journal:  Am J Prev Med       Date:  1995 Mar-Apr       Impact factor: 5.043

View more
  5 in total

1.  Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.

Authors:  Fangjian Guo; Jacqueline M Hirth; Abbey B Berenson
Journal:  J Womens Health (Larchmt)       Date:  2017-08-25       Impact factor: 2.681

2.  Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis.

Authors:  Marialaura Simonetto; Stephanie Rutrick; Natalie M LeMoss; Kelsey N Lansdale; Scott T Tagawa; Hooman Kamel; Neal Parikh; Babak B Navi
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-01-13       Impact factor: 2.136

3.  Chronic Comorbidities and Receipt of Breast Cancer Screening in United States and Foreign-Born Women: Data from the National Health Interview Survey.

Authors:  Leslie E Cofie; Jacqueline M Hirth; Abbey B Berenson; Rebeca Wong
Journal:  J Womens Health (Larchmt)       Date:  2018-12-28       Impact factor: 2.681

4.  Understanding Barriers to Cervical Cancer Screening in Women With Access to Care, Behavioral Risk Factor Surveillance System, 2014.

Authors:  Anatasha Crawford; Vicki Benard; Jessica King; Cheryll C Thomas
Journal:  Prev Chronic Dis       Date:  2016-11-10       Impact factor: 2.830

5.  Predictors of cervical cancer screening among Kenyan women: results of a nested case-control study in a nationally representative survey.

Authors:  Anne Ng'ang'a; Mary Nyangasi; Nancy G Nkonge; Eunice Gathitu; Joseph Kibachio; Peter Gichangi; Richard G Wamai; Catherine Kyobutungi
Journal:  BMC Public Health       Date:  2018-11-07       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.